Zafirlukast
Back to searchScientific Name: | Zafirlukast |
Brand Name: | Accolate |
Company Owner: | Astrazeneca uk ltd |
Mechanism Of Action | Zafirlukast is a selective and competitive receptor antagonist of leukotriene D4 and E4 (LTD |
Description of the Drug: | Zafirlukast is a leukotriene receptor antagonist used for prophylaxis and chronic treatment of asthma. |
Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00549